Kathi Niffenegger's most recent trade in Edesa Biotech Inc was a trade of 8,888 Common Shares done at an average price of $1.1 . Disclosure was reported to the exchange on Nov. 2, 2022.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Edesa Biotech Inc | Kathi Niffenegger | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 1.12 per share. | 02 Nov 2022 | 8,888 | 10,715 (0%) | 0% | 1.1 | 9,999 | Common Shares |
| Edesa Biotech Inc | Kathi Niffenegger | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Nov 2022 | 4,444 | 4,444 | - | - | Common Share Warrants (Right to Buy) | |
| Edesa Biotech Inc | Kathi Niffenegger | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Nov 2022 | 4,444 | 4,444 | - | - | Common Share Warrants (Right to Buy) | |
| Edesa Biotech Inc | Kathi Niffenegger | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2022 | 43,500 | 43,500 | - | - | Stock Option (right to buy) | |
| Edesa Biotech Inc | Kathi Niffenegger | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Apr 2021 | 80,000 | 80,000 | - | - | Stock Option (right to buy) | |
| Edesa Biotech Inc | Kathi Niffenegger | Chief Financial Officer | 06 Nov 2020 | 609 | 0 | - | - | Common Share Warrants (Right to Buy) | ||
| Edesa Biotech Inc | Kathi Niffenegger | Chief Financial Officer | 06 Nov 2020 | 609 | 1,827 (0%) | 0% | 4 | 2,436 | Common Shares | |
| Edesa Biotech Inc | Kathi Niffenegger | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Oct 2020 | 50,000 | 50,000 | - | - | Stock option (right to buy) |